Загрузка...
The New ELN Recommendations for Treating CML
After normal survival has been achieved in most patients with chronic myeloid leukemia (CML), a new goal for treating CML is survival at good quality of life, with treatment discontinuation in sustained deep molecular response (DMR; MR(4) or deeper) and treatment-free remission (TFR). Four tyrosine...
Сохранить в:
| Опубликовано в: : | J Clin Med |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7697560/ https://ncbi.nlm.nih.gov/pubmed/33207600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113671 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|